login
login

Europe Daily Bulletin No. 8374

9 January 2003
Contents Publication in full By article 32 / 36
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The venture capital company HG CAPITAL has acquired, for the sum of EUR 40 million, a controlling stake of 73% in the Dutch company, PBR - PHARMA BIO-RESEARCH. The operation gives the company a value of EUR 90 million, debt included.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION
SUPPLEMENT